Previous 10 | Next 10 |
2023-03-19 02:02:19 ET Summary KIDS expects its top line expansion to slow in the current year, due to pediatric hospitals' staffing challenges and the potential deferral of elective surgeries. On the other hand, OrthoPediatrics' recent acquisitions and its differentiated strategy...
WARSAW, Ind., March 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced it was recently named one of the 2023 Best Plac...
OrthoPediatrics Corp (KIDS) Q4 2022 Results Earnings Conference Call March 1, 2023, 08:00 AM ET Company Participants Philip Taylor - Investor Relations, Gilmartin Group David Bailey - President and Chief Executive Officer Fred Hite - Chief Financial Officer and Chief O...
OrthoPediatrics press release ( NASDAQ: KIDS ): Q4 GAAP EPS of -$0.35 misses by $0.09 . Revenue of $30.99M (+24.9% Y/Y) misses by $1.13M . Reiterated full year 2023 revenue guidance to be in a range of just over $146.0 million to $149.0 million vs. $148.79M consen...
Fourth Quarter 2022 Revenue Increased 25% Year-over-Year Full Year 2022 Revenue Increased 25% Year-over-Year WARSAW, Ind., Feb. 28, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a com...
WARSAW, Ind., Feb. 14, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth...
WARSAW, Ind., Feb. 01, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the publication of an Environmental, Social, an...
Pediatric orthopedics company OrthoPediatrics ( NASDAQ: KIDS ) issued Q4, FY22 and FY23 guidance below consensus. The company said its Q4 net revenue is expected to be $31M, vs. consensus of $33.18M, represents a growth of 25% Y/Y. The Q4 domestic net revenue growth ...
WARSAW, Ind., Jan. 09, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced preliminary unaudited net revenue for the fourth qu...
WARSAW, Ind., Jan. 06, 2023 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the establishment of its direct sales organizat...
News, Short Squeeze, Breakout and More Instantly...
OrthoPediatrics Corp. Company Name:
KIDS Stock Symbol:
NASDAQ Market:
OrthoPediatrics Corp. Website:
WARSAW, Ind., April 22, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused e...
WARSAW, Ind., April 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics") (NASDAQ:KIDS), a company focused exclusively on advan...
WARSAW, Ind., March 26, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS) a company focused excl...